Uzbekistan cough syrup deaths: Centre recommends cancellation of company’s manufacturing licence
Cough syrup deaths in Uzbekistan: The central government recommended the suspension of Marion biotech’s manufacturing license in Noida after 22 of the 36 samples taken for testing were adulterated with ethylene glycol, Drug Inspector Gautam Budh Nagar said on Saturday.
According to the drug inspector of Gautam Budh Nagar, Uttar Pradesh, “The Center is recommending the State Drug Controller Authority to revoke Marion biotech’s production license after 22 of the 36 samples taken for its testing were adulterated with ethylene glycol.”
On March 4, the Uttar Pradesh Drugs Controlling and Licensing Authority advised the center on its license revocation after it was found that the company was using substandard syrups. The Marion Biotech company had supplied the cough syrups that allegedly caused the deaths of children in Uzbekistan.
The Marion Biotech Pvt Ltd had come under scrutiny last December for its cough syrup Dok-1, which is believed to have led to the deaths of 18 children consuming it in Uzbekistan, prompting the CDSCO to launch an investigation into the matter.
Earlier on Friday, Noida police arrested three people for manufacturing and selling duplicate drugs linked to the pharmaceutical company that produced cough syrup whose use allegedly led to the deaths of several children in Uzbekistan last year.
The suspects have been identified as Atul Rawat, Tuhin Bhattacharya and Mool Singh and were arrested by Marion Biotech Pvt Ltd. The case was registered at Gautam Buddha Nagar Phase-3 Police Station under various sections of the Drugs and Cosmetics Act 1940. A probe had been launched last year at the Noida-based drug manufacturer following the deaths of 18 children in Uzbekistan.
READ ALSO | Cough syrup deaths in Uzbekistan: 3 Noida-based pharmaceutical company officials arrested
READ ALSO | The WHO advises against the use of cough syrups from Marion Biotech from Noida in Uzbekistan
Latest India News
